<DOC>
	<DOCNO>NCT01041807</DOCNO>
	<brief_summary>This survey conduct prepare application material re-examination Pharmaceutical Affairs Law Enforcement Regulation ; aim reconfirm clinical usefulness COZAAR XQ collect safety efficacy information accord Re-examination Regulation New Drugs .</brief_summary>
	<brief_title>Cozaar XQ Re-examination Study ( MK-0954-349 )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion criterion : Participant essential hypertension Participant treat COZAAR XQ within local label first time Exclusion criterion : Participant treat COZAAR XQ contract enrollment period Participant contraindication COZAAR XQ accord local label</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Hypertension</keyword>
</DOC>